Cargando…

The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory

INTRODUCTION: Primary immune deficiency disorders (PIDs) are a group of diseases with profound defects in immune cells. The traditional diagnostics have evolved from clinical evaluation, flow cytometry, western blotting, and Sanger sequencing to focusing on small groups of genes. However, this is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisgin, Atil, Boga, Ibrahim, Yilmaz, Mustafa, Bingol, Gulbin, Altintas, Derya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977064/
https://www.ncbi.nlm.nih.gov/pubmed/29888287
http://dx.doi.org/10.1155/2018/9647253
_version_ 1783327296204046336
author Bisgin, Atil
Boga, Ibrahim
Yilmaz, Mustafa
Bingol, Gulbin
Altintas, Derya
author_facet Bisgin, Atil
Boga, Ibrahim
Yilmaz, Mustafa
Bingol, Gulbin
Altintas, Derya
author_sort Bisgin, Atil
collection PubMed
description INTRODUCTION: Primary immune deficiency disorders (PIDs) are a group of diseases with profound defects in immune cells. The traditional diagnostics have evolved from clinical evaluation, flow cytometry, western blotting, and Sanger sequencing to focusing on small groups of genes. However, this is not sufficient to confirm the suspicion of certain PIDs. Our innovative approach to diagnostics outlines the algorithm for PIDs and the clinical utility of immunophenotyping with a custom-designed multigene panel. MATERIALS AND METHODS: We have designed a diagnostic algorithm based on flow cytometry studies to classify the patients; then the selected multigene panel was sequenced. In silico analysis for mutations was carried out using SIFT, Polyphen-2, and MutationTaster. RESULTS AND DISCUSSION: The causative mutation was identified in 46% of PIDs. Based on these results, this new algorithm including immune phenotyping and NGS for PIDs was suggested for the clinical use. CONCLUSIONS: This study provides a thorough validation of diagnostic algorithm and indicates that still the traditional methods can be used to collect significant information related to design of most current diagnostics. The benefits of such testing are for diagnosis and prevention including the prenatal and preimplantation diagnosis, prognosis, treatment, and research.
format Online
Article
Text
id pubmed-5977064
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59770642018-06-10 The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory Bisgin, Atil Boga, Ibrahim Yilmaz, Mustafa Bingol, Gulbin Altintas, Derya Biomed Res Int Research Article INTRODUCTION: Primary immune deficiency disorders (PIDs) are a group of diseases with profound defects in immune cells. The traditional diagnostics have evolved from clinical evaluation, flow cytometry, western blotting, and Sanger sequencing to focusing on small groups of genes. However, this is not sufficient to confirm the suspicion of certain PIDs. Our innovative approach to diagnostics outlines the algorithm for PIDs and the clinical utility of immunophenotyping with a custom-designed multigene panel. MATERIALS AND METHODS: We have designed a diagnostic algorithm based on flow cytometry studies to classify the patients; then the selected multigene panel was sequenced. In silico analysis for mutations was carried out using SIFT, Polyphen-2, and MutationTaster. RESULTS AND DISCUSSION: The causative mutation was identified in 46% of PIDs. Based on these results, this new algorithm including immune phenotyping and NGS for PIDs was suggested for the clinical use. CONCLUSIONS: This study provides a thorough validation of diagnostic algorithm and indicates that still the traditional methods can be used to collect significant information related to design of most current diagnostics. The benefits of such testing are for diagnosis and prevention including the prenatal and preimplantation diagnosis, prognosis, treatment, and research. Hindawi 2018-05-16 /pmc/articles/PMC5977064/ /pubmed/29888287 http://dx.doi.org/10.1155/2018/9647253 Text en Copyright © 2018 Atil Bisgin et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bisgin, Atil
Boga, Ibrahim
Yilmaz, Mustafa
Bingol, Gulbin
Altintas, Derya
The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory
title The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory
title_full The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory
title_fullStr The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory
title_full_unstemmed The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory
title_short The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory
title_sort utility of next-generation sequencing for primary immunodeficiency disorders: experience from a clinical diagnostic laboratory
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977064/
https://www.ncbi.nlm.nih.gov/pubmed/29888287
http://dx.doi.org/10.1155/2018/9647253
work_keys_str_mv AT bisginatil theutilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT bogaibrahim theutilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT yilmazmustafa theutilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT bingolgulbin theutilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT altintasderya theutilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT bisginatil utilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT bogaibrahim utilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT yilmazmustafa utilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT bingolgulbin utilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory
AT altintasderya utilityofnextgenerationsequencingforprimaryimmunodeficiencydisordersexperiencefromaclinicaldiagnosticlaboratory